ALPS (ALPS Group) EBITDA Margin %: -41.64% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALPS ALPS Group Inc ALPS
10 GF Score
Price $0.38
! 1 Warning Sign
View Full Analysis

What is ALPS Group EBITDA Margin %?

ALPS Group ALPS -0.03% 10 EBITDA Margin % is -41.64% as of Mar. 2026. GuruFocus rates ALPS with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 946 Biotechnology companies, ALPS Group ranks better than 52.75% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ALPS Group's EBITDA for the six months ended in Mar. 2026 was $-2.02 Mil. ALPS Group's Revenue for the six months ended in Mar. 2026 was $4.86 Mil. Therefore, ALPS Group's EBITDA margin for the quarter that ended in Mar. 2026 was -41.64%.

ALPS Group  (NAS:ALPS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ALPS Group EBITDA Margin % Related Terms

ALPS Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for ALPS Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ALPS Group EBITDA Margin % Chart

ALPS Group Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EBITDA Margin %
10.10 -60.40 -40.11 -18.55

ALPS Group Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Margin % Get a 7-Day Free Trial 0.00 0.00 -73.48 0.00 -41.64

ALPS vs RNTX, HYFT, PMVP: EBITDA Margin % Comparison

For the Biotechnology subindustry, ALPS Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ALPS Group EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ALPS Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ALPS Group's EBITDA Margin % falls into.


ALPS
10GF Score
ALPS Group Inc ALPS
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ALPS Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ALPS Group's EBITDA Margin % for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-0.901/4.856
=-18.55 %

ALPS Group's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.022/4.856
=-41.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -41.64% mean?
ALPS Group (ALPS) has a EBITDA Margin % of -41.64% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ALPS Group and its competitors. According to the industry distribution chart, ALPS Group ranks #447 out of 946 companies in the Biotechnology industry, placing it in the top 47.3%.
Is ALPS Group's EBITDA Margin % too high?
ALPS Group's current EBITDA Margin % is -41.64%. Based on the distribution chart, ALPS Group ranks #447 out of 946 companies in the Biotechnology industry, which is above the industry midpoint. Overall, ALPS Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does ALPS Group's EBITDA Margin % compare to RNTX and HYFT?
According to the Biotechnology industry distribution chart, ALPS Group ranks #447 out of 946 companies for EBITDA Margin %. This puts ALPS Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ALPS Group and its competitors. ALPS Group's current EBITDA Margin % is -41.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALPS Group stock overvalued right now?
ALPS Group (ALPS) has a current EBITDA Margin % of -41.64%. The current EBITDA Margin % is -41.64%. ALPS Group's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ALPS Group (ALPS), the current EBITDA Margin % is -41.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ALPS Group Business Description

Address Jalan 1/68th Floor, Off Jalan Tun Razak, The ICON, East Wing Tower, Level 18-01 & 18-02, No.1, Kuala Lumpur, MYS, 50400
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
10GF Score

Get the complete analysis for ALPS

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.38
Price